• 3
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
GPC3 (HGNC:4451) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
glypican 3
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
SDYS
Alias symbols
OCI-5, SGBS, SGBS1, SGB, DGSX
%HI
1.17(Read more about the DECIPHER Haploinsufficiency Index)
pLI
1(Read more about gnomAD pLI score)
LOEUF
0.16(Read more about gnomAD LOEUF score)
Cytoband
Xq26.2
Genomic Coordinates
GRCh37/hg19: chrX:132669773-133119621 NCBI Ensembl UCSC
GRCh38/hg38: chrX:133535745-133985594 NCBI Ensembl UCSC
MANE Select Transcript
NM_004484.4 ENST00000370818.8 (Read more about MANE Select)
Function
Cell surface proteoglycan (PubMed:14610063). Negatively regulates the hedgehog signaling pathway when attached via the GPI- anchor to the cell surface by competing with the hedgehog receptor PTC1 for binding to hedgehog proteins (By similarity). Binding to the hedgehog protein SHH triggers internalization of the complex by endocytosis and its subsequent lysosomal degradation (By similarity). Positively regulates the canonical Wnt signaling pathway by binding to the Wnt receptor Frizzled and stim... (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-32790
ClinGen Curation ID:
CCID:007236
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
01/27/2021

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
  • Simpson-Golabi-Behmel syndrome type 1 Monarch
HI Evidence:
  • PUBMED: 30447178
    Vuillaume et al. (2018) reviewed 57 previously described GPC3 variants identified in 71 unrelated families. In addition they identified and additional 38 GPC3 variants in tn a patient cohort of 49 unrelated families. Variant types included large deletions (34.9%) followed by frameshift mutations leading to a stop premature codon (24.4%), nonsense (16.3%), missense (8.1%), large intragenic duplications (8.1%), splice site mutations (4.7%), translocations (2.3%), and one in frame mutation (1.2%).
  • PUBMED: 21362501
    Weichert et al. (2011) reported the prenatal findings of a fetus with a 1 MB deletion that includes the entire GPC3 gene, arr Xq26.2(132191191_133257323)x0; NCBI Build 36.1) and encompassing GPC4, GPC3 and CCDC160 . The most commonly found antenatal features of postnatally confirmed cases of SGBS1 included craniofacial anomalies, marked macrosomia, increased nuchal translucency and polyhydramnios.
  • PUBMED: 10814714
    Veuglelers et al. (2000) identified 6 SBGS1 patients with variants predicted to result in loss of function (1 frameshift, 3 nonsense, 1 splice site, 1 intragenic deletion . Expression analysis studies of one missense variant W296R that changes a highly conserved amnio acid resulted in a poorly processed protein and failed to increase the cell surface expression of heparan sulfate, suggesting that this missense mutation is also a loss-of-function mutation.
HI Evidence Comments:
Pathogenic variants resulting loss of function including splice site, frameshift, nonsense variants, intragenic deletions, intragenic duplications and whole gene deletions of the GPC3 gene have been found in males with Simpson-Golabi-Behmel syndrome type 1 (SGBS1). Clinical features of SGBS1 include pre- and post-natal overgrowth, developmental delay, macrocephaly, and distinct facial features. Additional features which may be seen include congenital heart defects, kidney anomalies and skeletal anomalies and an increased risk of embryonal cancers. Additional PMIDs include 6538755, 8589713,9192268. Females are typically asymptomatic although some females have been noted with various features. Skewed X-inactivation has been a suggested explanation for clinical expression in some females. Additional PMIDs include 2739211and 30048822.
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)